drugset
drugset / Trial / NCT04709185

AVS After 1mg DST to Determine Subtype in PA

NCT04709185 ↗

Completed 110 enrolled Shanghai Zhongshan Hospital
RandomizedParallel-groupDouble-blindDiagnostic

Summary

To compare the effect of different procedures of AVS(after 1mg DST or not) in determining the subtypes and long-term outcomes of PA

Timeline

Start
2021-01-08
Primary completion
2022-10-30
Completion
2022-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 1 mg Oral

Indications

primary aldosteronism